This open label, prospective observational, single-center registry is to study short-, intermediate-and long-term course of postpartum hypertension and predictors/risk factors associated with long term cardiovascular and renal risk. Current disease management strategies will be evaluated.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Frequency of persistent hypertension defined by 24 hours BP measurement
Timeframe: through study completion, an average of 5 years
Frequency of persistent hypertension defined by office blood pressure measurement (OBPM, AOBPM)
Timeframe: through study completion, an average of 5 years
Frequency of microalbuminuria
Timeframe: through study completion, an average of 5 years
Frequency of damage to the retina of the eyes (retinopathy)
Timeframe: through study completion, an average of 5 years
Signs of hypertensive heart disease
Timeframe: up to 24 months
Frequency of dyslipidemia
Timeframe: through study completion, an average of 5 years
Frequency of prediabetes/diabetes
Timeframe: through study completion, an average of 5 years